|Day Low/High||2.79 / 2.94|
|52 Wk Low/High||2.15 / 6.30|
The Plymouth Meeting, Pa.-based firm said a Phase 1 study of Zika vaccine GLS-5700 'induced high levels of binding antibodies in 100% of participants.'
Identifying this week's bullish and bearish reversal patterns.
These four biotech stocks have been moving on some interesting news and clinical results.
I am happy to be standing in for Doug Kass this Friday morning as we end what has been a somewhat volatile week for trading. The big banks such as Citicorp and Wells Fargo are due to report before the bell this morning as we get further along into t...
The market is basically flat across the board to start the new week, but biotechs are strong overall in early going following news that Pfizer plans to buy Medivation for $14 billion. The sector's movers include some biotechs that I hold. For instan...
Inovio Pharmaceuticals and Eagle Pharmaceuticals both boast solid pipelines and sound balance sheets.
Looking for a breakout on banks and bonds.
Here's what to make of the selling in IBM and Netflix that came after earnings and after the bell.
Also a stock to combat the Zika virus, and another that fights off viruses of the cyber kind.
U.S. equities opened higher on Wednesday as oil prices rallied on hopes Iran would agree to a production freeze.
It's something we should have on our radar as yet another potential Black Swan for this market and economy.
Key collaboration deals with deeper-pocketed concerns can improve the odds of investment success.